Blog

This is the typical refrain from so many of our clients who were implanted with defective metal-on-metal hip implants made by orthopedic giants like DePuy, Stryker, Wright Medical, and Zimmer. The irony is that those who utter those words are actually very close to the emerging stereotype for these clients. […]

The “antipsychotic” class of drugs is distributed liberally in nursing homes. Antipsychotics including Risperdal, Seroquel, Zyprexa, and Abilify, are frequently given to the elderly who are suffering from dementia so they are easier to control. It’s a handy tool in a nursing home that is understaffed and needs to find […]

A newly published study finds that first-time users of a class of drugs to treat osteoporosis may be at an increased risk of serious inflammatory eye disease. Bisphosphonates such as Fosamax and Actonel, which are taken orally, are two of the most commonly prescribed drugs in that class. Published in […]

The Mentor ObTape Sling is a transobturator vaginal sling, which was manufacturer by Mentor Corporation and was implanted in thousands of women to treat Stress Urinary Incontinence (SUI). Mentor’s ObTape replaced Mentor’s Uratape product. Uratape performed so poorly that Mentor quit selling it after an embarrassingly short time on the […]

We hear from them every day  – consumers who trust and believe their doctor  only to find out things like what Consumer Reports (CR) investigates in its May issue. Surprisingly, the majority of medical devices never have to pass through any sort of safety and efficacy standard with the Food […]

Better late than never? The U.S. Food and Drug Administration (FDA) will hold a gathering of scientific and clinical experts to discuss whether metal-on-metal (MoM) artificial hip systems should undergo more rigorous scientific scrutiny before they are implanted in U.S. patients, which sounds infinitely reasonable. On Thursday, March 29, the […]

The U.S. Food and Drug Administration (FDA) has revised its recommendations for the popular antidepressant, Celexa (citalopram hydrobromide). Last August, the FDA warned Celexa should be limited to doses no greater than 40 mg per day because of a risk of abnormal electrical activity in the heart known as Torsade […]

Johnson & Johnson (J&J) rarely responds to negative news, which it’s been experiencing a lot of lately, usually relying on the news cycles to wash away unfavorable reports. But in an unusual move, a J&J spokesman recently did defend the company from the latest blow – that the health care […]

It’s little known and rarely applied but the Park doctrine does allow the U.S. government to file a misdemeanor criminal charge against corporate officials even if they didn’t intend to violate any law. The law is based on the conviction of a Mr. John Park, who owned Acme Markets, a […]

On March 26, 2012, Searcy Denney filed two additional individual lawsuits against Bayer Corporation, the manufacturer of Yasmin and Yaz. One of the new cases was filed on behalf of a married Texas woman who works as a Head Start teacher.  She started taking Yasmin in 2008, and quickly developed […]